Dr. Maria Rivera, MD, FACP
Dr. Maria Rivera is a board-certified internal-medicine physician with a clinical focus on endocrine and metabolic care. Over fifteen years of bedside practice she has supervised the initiation of injectable therapies, insulin, GLP-1 receptor agonists, and dual GIP/GLP-1 agonists, for thousands of patients in primary-care and weight-management clinics. Her interest in patient-education clarity grew out of repeatedly seeing the same questions about pen technique, dose-stepping schedules, and what to do when a dose is missed; the answers she gives in clinic form the clinical sanity check on every InjectCompass post tagged `medicalDisclaimer: required`. She reviews drafts for safety framing, dose accuracy against current FDA labels, and the absence of any language that could be read as personalized medical advice. Dr. Rivera trained at UCSF and completed her residency in internal medicine at the same institution. She holds active medical licenses in California and Nevada and reports no financial relationships with pharmaceutical manufacturers, telehealth clinics, or compounding pharmacies.
Education and training
- University of California, San Francisco. School of Medicine
Areas of clinical focus
- GLP-1 receptor agonists
- Subcutaneous injection technique
- Type 2 diabetes management
- Lifestyle and metabolic medicine
Licenses
Dr. Maria Rivera holds an active medical license in: California, Nevada.
Articles reviewed by Rivera
Per-article reviewer attributions are being backfilled, they will appear here once the full editorial pipeline has tagged each medicalDisclaimer: required post with its assigned reviewer. In the interim, the reviewer assigned to a given post is named in the article header.
Disclosures
Dr. Maria Rivera reports no financial relationships with pharmaceutical manufacturers, telehealth clinics, peptide vendors, or compounding pharmacies. The full editorial-review process and disclosure policy is documented at /editorial-standards.